OQS Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Installed Base And Recurring RevenueA larger installed base expands the pool generating consumables and service revenue, improving recurring visibility beyond one-off placements. Continued upgrades support lifecycle monetisation, while annuity growth shows the ecosystem is scaling.
CORIS Product ExpansionRegulatory progress gives Nanosonics access to a broader infection-prevention market and establishes a second platform alongside trophon. CORIS’s higher pricing, cycle capacity and service potential could create a durable growth avenue.
Strong Balance Sheet And Trophon Cash EngineSubstantial cash and minimal financial leverage provide resilience and funding for CORIS commercialisation, manufacturing expansion and shareholder returns. Trophon’s strong profitability supplies an established internal cash engine for future investment.
Bears Say
Growth Softness And APAC WeaknessThe recent revenue slowdown indicates execution and market-development challenges despite longer-term growth. APAC weakness, linked to placement mix and rental models, may limit geographic diversification and delay recovery in regional demand.
Margin Pressure From Costs And MixTariffs, freight and product mix are reducing the margin buffer that supports earnings growth. Even with strong underlying gross margins, persistent cost pressure could constrain operating leverage and make profitability more dependent on pricing.
CORIS Launch Investment And Delayed ReturnsThe launch requires substantial spending before revenue scales, creating a period of weaker earnings leverage and execution risk. Limited initial sales mean returns depend on successful adoption and acceleration beyond the first commercial year.
Nanosonics Limited News
OQS FAQ
What was Nanosonics Limited’s price range in the past 12 months?
Currently, no data Available
What is Nanosonics Limited’s market cap?
Nanosonics Limited’s market cap is CHF489.51M.
When is Nanosonics Limited’s upcoming earnings report date?
Nanosonics Limited’s upcoming earnings report date is Feb 23, 2027 which is in 179 days.
How were Nanosonics Limited’s earnings last quarter?
Nanosonics Limited released its earnings results on Aug 24, 2026. The company reported CHF0.017 earnings per share for the quarter, beating the consensus estimate of CHF0.014 by CHF0.002.
Is Nanosonics Limited overvalued?
According to Wall Street analysts Nanosonics Limited’s price is currently Undervalued.
Does Nanosonics Limited pay dividends?
Nanosonics Limited does not currently pay dividends.
What is Nanosonics Limited’s EPS estimate?
Nanosonics Limited’s EPS estimate is 0.01.
How many shares outstanding does Nanosonics Limited have?
Nanosonics Limited has 298,718,260 shares outstanding.
What happened to Nanosonics Limited’s price movement after its last earnings report?
Nanosonics Limited reported an EPS of CHF0.017 in its last earnings report, beating expectations of CHF0.014. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Nanosonics Limited?
Currently, no hedge funds are holding shares in CH:OQS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nanosonics Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
CHF1.79 (― Upside)
CHF1.79 (― Upside)
Blogger Sentiment
Bullish
CH:OQS Sentiment 100%
Sector Average 60%
Sector Average 60%
Insider Transactions
Bought Shares
Worth CHF16.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Bullish
Bullish news 75%
Bearish news 25%
Bearish news 25%
Technicals
SMA
Positive
20 days / 200 days
Momentum
71.59%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
18.98%
Trailing 12-Months
Company Description
Nanosonics Limited
Nanosonics Limited, along with its subsidiaries, functions as a global infection prevention enterprise with operations in Australia and beyond. The company focuses on the production and distribution of its trophon ultrasound probe disinfection system, including all related supplies and accessories. Additionally, it dedicates resources to the exploration, development, and market launch of innovative infection control, decontamination products, and their associated technologies. Key offerings from Nanosonics include trophon2, an advanced device for high-level disinfection of ultrasound probes; trophon EPR, a low-temperature, high-level disinfection method specifically for intra-cavity ultrasound probes; and Nanosonics AuditPro, a comprehensive solution for managing compliance with infection control workflows. Established in 2000, Nanosonics Limited is headquartered in Macquarie Park, Australia.
OQS Company Deck
OQS Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive operational and financial picture: constant-currency revenue and EBIT growth, strong trophon profitability and cash generation, record placements and upgrades, product innovation (trophon3/trophon2 Plus), solid annuity and service growth, a debt-free balance sheet with substantial cash and an active buyback. Management also delivered substantial regulatory and commercial progress for CORIS and set explicit FY'27 guidance that anticipates continued growth. Negative items are present but largely manageable and/or transitional: a Q3 consumables dip due to weather, margin moderation from product mix and currency, APAC softness tied to rental models, and elevated near-term OpEx to fund CORIS commercialization which will weigh on near-term profitability. Overall, highlights substantially outweigh the lowlights, with CORIS viewed as a meaningful long-term growth opportunity while trophon continues as a strong cash engine.View all CH:OQS earnings summariesOQS Stock 12 Month Forecast
Average Price Target
―Ansell
―
Polynovo
―
Paragon Care Limited
―
Trajan Group Holdings Ltd
―
CleanSpace Holdings Ltd.
―